Brief Report: HIV Drug Resistance in Adults Failing Early Antiretroviral Treatment: Results from the HIV Prevention Trials Network 052 Trial

• Main Authors: Fogel J., Hudelson S., Ou S., Hart S., Wallis C., Morgado M., Saravanan S., Tripathy S., Hovind L., Piwowar-Manning E., Sabin D., McCauley M., Gamble T., Zhang X., Eron J., Gallant J., Kumwenda J., Makhema J., Kumarasamy N., Chariyalertsak S., Hakim J., Badal-Faesen S., Akelo V., Hosseinipour M., Santos B., Godbole S., Pilotto J., Grinsztejn B., Panchia R., Mayer K., Chen Y., Cohen M., Eshleman S.
• 格式: 雜誌
• 出版: 2017
• 在線閱讀: https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84976315930&origin=inward; http://cmuir.cmu.ac.th/jspui/handle/6653943832/41786
• 機構: Chiang Mai University

© Copyright 2016 Wolters Kluwer Health, Inc. All rights reserved. Early initiation of antiretroviral treatment (ART) reduces HIV transmission and has health benefits. HIV drug resistance can limit treatment options and compromise use of ART for HIV prevention. We evaluated drug resistance in 85 part...